Dogma Therapeutics - Ownership and Business Overview

Life ScienceCompany

Dogma Therapeutics Ownership

Who owns Dogma Therapeutics?

.

Dogma Therapeutics Business Overview

Where is Dogma Therapeutics headquartered?

Dogma Therapeutics is headquartered in Boxford, Massachusetts.

What sector is Dogma Therapeutics in?

Dogma Therapeutics is a life science company.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Dogma Therapeutics

4 Dana Road,
Boxford, Massachusetts 01921
United States,
www.dogmatherapeutics.com

Dogma Therapeutics has discovered bona fide small molecule inhibitors of PCSK9 function that are orally bioavailable across multiple preclinical species. Guided by dozens of high-resolution x-ray structures of molecules bound to PCSK9 that utilize structure-based design to achieve picomolar affinity.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - 1 - - - - 1
  1

Most Recent M&A

Company Date Value Type
Dogma's Oral PCSK9 Inhibitor Program 2020-09-17 - Divestiture
Boxford, Massachusetts
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) -
Total - - 1 -

By Geo

State/Country Buy Value Sell Value
United States - - 1 -
  Massachusetts - - 1 -
Total - - 1 -

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.